机译:白细胞介素-6受体阻断选择性地通过CD4 T细胞和ingg4自身抗体在类风湿性关节炎中减少IL-21产生
Department of Medicine Division of Rheumatology University of Vermont Burlington VT 05405;
Department of Medicine Division of Rheumatology University of Vermont Burlington VT 05405;
Division of Immunobiology University of Vermont Burlington VT 05405 United States;
Department of Mathematics and Statistics University of Vermont Burlington VT05405 United States;
Department of Medicine Division of Rheumatology University of Vermont Burlington VT 05405;
Department of Medicine Division of Rheumatology University of Vermont Burlington VT 05405;
Auti-CCP; CD4 T; IgG4; IL-21; IL-6; Interleukin-6; Rheumatoid arthritis; Tocilizumab;
机译:白细胞介素6受体阻滞剂选择性降低类风湿关节炎中CD4 T细胞和IgG4自身抗体产生的IL-21
机译:白介素6受体阻滞剂选择性降低类风湿关节炎中CD4 T细胞和IgG4自身抗体的IL-21产生。
机译:白细胞介素-6受体阻断选择性地通过CD4 T细胞和ingg4自身抗体在类风湿性关节炎中减少IL-21产生
机译:类风湿性关节炎患者外周血CD4 + CD25 + T调节细胞和FOXP3的表达
机译:类风湿性关节炎的自身抗体
机译:白介素6受体阻滞剂选择性降低类风湿关节炎中CD4 T细胞和IgG4自身抗体的IL-21产生。
机译:白细胞介素-6受体封闭细胞选择性地通过CD4 T细胞和类风湿性关节炎中的IgG4自身抗体产生IL-21产生